Extensive Small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-01-22
Clinical Trial Update: A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) [Phase 3]
Phase 3 trial evaluating TQB2450 or placebo with Anlotinib, Etoposide, and Carboplatin versus Etoposide and Carboplatin in extensive small c…